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Introduction
Scleroderma is a highly complex disorder in its clinical
manifestations and pathogenesis. It has a wide range of
clinical manifestations due to varying degrees of vascu-
lopathy, autoimmunity, altered endothelium function,
and abnormal fibrosis which were accused in the patho-
genesis of the disease.
Objectives
The aim of this study be made of the cases diagnosed in
childhood with immune histochemical analysis is to
shed light on the pathogenesis of the disease.
Methods
Single-blind clinical trial. The tissue samples obtained
from patients PAS, hematoxylin and eosin, E-Cadherin,
CTGF, Tunnel, and staining for TGF-b1 is applied and
evaluated by light microscopy. Additionally, we have ana-
lyzed both TGFB1 level and mRNA expression analysis
in plasma and tissue samples from patients. A total of
15 patients were enrolled in the study. These patients,
who were chosen from, systemic (n = 8) or localized (n =
7) scleroderma patients clinically received, and for the
disease of any systemic untreated and scleroderma other
than skin disease.
Results
In the study a total of 22 tissue samples (15 diseased tis-
sue, healthy tissue and 7) were used. The mean age of
onset was 9.2 ± 1.2 years and the mean age of diagnosis
was 15.3 ± 3.2 years. All patients with systemic sclerosis
have antinuclear antibody (ANA) titer 1/160-1/640.
ANA positivity in patients with localized scleroderma
were no. Clinically with different characteristics in the
two subgroups of the histopathology examination was
shown to be distinct from the tissue level.
Conclusion
Playing a fundamental role in the pathogenesis of the
TGF-B levels in both plasma and skin have been shown
to be locally high. Particularly in patients with systemic
scleroderma this elevation was found to be more pro-
nounced. Treatment for this disease is still questionable
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